Titlebook: Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems; Bruce W. Dana (Clinical Associate Professor

Hdl348

cliche

CHOKE

宽敞

canonical

威胁你

Prognostic factors in intermediate high grade lymphoma,ually by survival. This information would lead to a more rational approach to an individual case where treatment to be offered to patients with a worse than average prognosis could be intensified or dramatically changed, while the better prognostic subgroup of patients could benefit from conventiona

crockery

Treatment of diffuse large-cell lymphoma: A summary of outcome for patients treated by the Southwesd with a potential for cure following initial treatment with doxorubicin-containing chemotherapy. Consequently, DLCL has become a chosen target of investigators testing new therapies designed for cure. By choosing to study a single morphologic disease, and by standardizing procedures used to determi

形状

易发怒

Lymphoblastic lymphoma, a disease having discreet pathologic and clinical features from diffuse, small cleaved cell lymphoma. In 1982, the National Cancer Institute sponsored study of 1175 adult patients [.] gave rise to the international Working Formulation of non-Hodgkin’s lymphomas, which recognized LBL as one of its 1

EVADE